Form 4: Abeona Therapeutics Director Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Mark Alvino, a director of Abeona Therapeutics, sold 25,890 shares of common stock on June 18, 2024, to cover tax obligations associated with vesting of restricted stock awards.

Summary

  • On June 18, 2024, Mark Alvino, a director of Abeona Therapeutics Inc., sold 25,890 shares of the company's common stock.
  • The shares were sold at a weighted average price of $4.51, with individual transactions ranging from $4.47 to $4.55.
  • The sale was executed to cover tax obligations related to the vesting of restricted stock awards.
  • Following the transaction, Alvino directly owns 36,926 shares of Abeona Therapeutics.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) by a company director, which is neither particularly positive nor negative.

Industry Context

Sales of shares by company directors are a common occurrence, often related to personal financial planning or tax obligations. It's important to consider the context of such sales, including the size of the transaction relative to the director's total holdings and any accompanying explanation.

Key Dates

DateDescription
06/17/2024Date of Earliest Transaction
06/18/2024Date of Transaction: Sale of Common Stock
06/20/2024Date of Signature

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.